ABIONYX PHARMA: cash_and_equivalents
| Value | {"amount": 3235000.0, "concept": "ifrs-full:CashAndCashEquivalents"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | ABIONYX PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T22:42:18.659153+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/6cf3ef2b-fb46-431a-a807-37bd2be65d60
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500785J7VIC5YPC96:2025-12-31Retrieved: 2026-08-23T22:42:18.659153+02:00
Raw response sha256:
df7f82c289c957874561346a37c93090…Cite as: FACTANKER, https://factanker.com/fact/6cf3ef2b-fb46-431a-a807-37bd2be65d60
History
- no predecessors — first report